Large-Scale Genomic Biobanks and Cardiovascular Disease
Purpose of review
Cardiovascular disease is a leading cause of morbidity and mortality worldwide and is the focus of extensive biomedical research. Large genetic consortia combining data from many traditional prospective cohort and ascertained case-control study designs have facilitated the discovery of genetic associations for a variety of cardiovascular diseases including diabetes, coronary artery disease, and hypertension. Biobank-based genetic studies offer an alternative whereby large populations are genotyped and linked to electronic health records.
Biobank sample sizes worldwide have surpassed even the largest genetic consortia and have yielded key insights into the genetic determinants of both common and rare cardiovascular phenotypes.
Herein, we provide an overview of the largest genomic biobanks and discuss the relevant advantages and challenges inherent to the biobank model of cohort generation and genomic study design.
KeywordsBiobanks Cardiovascular disease Genetics
Compliance with Ethical Standards
Conflict of Interest
Aeron M. Small, Christopher J. O’Donnell, and Scott M. Damrauer declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.WHO | The top 10 causes of death. WHO. 2017.Google Scholar
- 3.Mc Pherson R. A Common Allele On chromosome 9 associated with coronary heart disease. Science 2007;316.Google Scholar
- 4.Helgadottir A. A Common Variant On chromosome 9p21 affects the risk of myocardial infarction. Science 2007;316.Google Scholar
- 5.Samani NJ. Genomewide Association Analysis of coronary artery disease. N Engl J Med 2007;357.Google Scholar
- 8.• CARDIoGRAMplusC4D Consortium, Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes TL, et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013;45:25–33. This study represents an example of meta-analysis to characterize the genetic architecture of coronary artery disease, a common cardiovascular trait. Google Scholar
- 9.Preuss M, Konig IR, Thompson JR, Erdmann J, Absher D, Assimes TL, et al. Design of the Coronary ARtery DIsease genome-wide replication and meta-analysis (CARDIoGRAM) study: a genome-wide association meta-analysis involving more than 22 000 cases and 60 000 controls. Circ Cardiovasc Genet. 2010;3:475–83.CrossRefPubMedPubMedCentralGoogle Scholar
- 14.International Stroke Genetics Consortium (ISGC), Wellcome Trust case control consortium 2 (WTCCC2), Bellenguez C, Bevan S, Gschwendtner A, Spencer CC, et al. genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet. 2012;44:328–33.CrossRefGoogle Scholar
- 19.Psaty BM, O'Donnell CJ, Gudnason V, Lunetta KL, Folsom AR, Rotter JI, et al. Cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium: design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet. 2009;2:73–80.CrossRefPubMedPubMedCentralGoogle Scholar
- 25.China Kadoorie Biobank. 2017. http://www.ckbiobank.org/site/. Accessed February 2, 2018.
- 27.•• UK Biobank: Protocol for a large-scale prospective epidemiological resource, 2007, authored by the UK biobank board and staff. http://www.ukbiobank.ac.uk/wp-content/uploads/2011/11/UK-Biobank-Protocol.pdf. This is the design protocol for the UK Biobank.
- 28.UK Biobank. 2017. http://www.ukbiobank.ac.uk/. Accessed February 2, 2018.
- 29.•• Gaziano JM, Concato J, Brophy M, Fiore L, Pyarajan S, Breeling J, Whitbourne S, Deen J, Shannon C, Humphries D, Guarino P, Aslan M, Anderson D, LaFleur R, Hammond T, Schaa K, Moser J, Huang G, Muralidhar S, Przygodzki R and O'Leary TJ. Million Veteran Program: A mega-biobank to study genetic influences on health and disease. J Clin Epidemiol. 2016;70:214–23. This article describes the design and objectives for the Million Veteran Program, a mega-biobank of US veterans. Google Scholar
- 30.The Precision Medicine Initiative Cohort Program - Building a Research Foundation for 21st Century Medicine. Precision Medicine Initiative (PMI) Working Group Report to the Advisory Committee to the Director, NIH 2015.Google Scholar
- 34.Auria Biopankki. https://www.auriabiopankki.fi/?lang=en. Accessed October 27, 2017.
- 35.deCODE Genetics. https://www.decode.com/. Accessed October 27, 2017.
- 37.Kaiser Permanente. Research Program on Genes, Environment and Health. https://divisionofresearch.kaiserpermanente.org/genetics/rpgeh Accessed October 27, 2017.
- 42.Gravel S. Demographic History and rare allele sharing among human populations. PNAS 2011;108.Google Scholar
- 43.Shae S. Accelerating The use of electronic health Records in Physician Practices. N Engl J Med 2010;362.Google Scholar
- 45.eMERGE network (Electronic Medical Records and Genomics): https://emerge.mc.vanderbilt.edu/. Accessed October 27, 2017.
- 46.Kho AN. Electronic Medical Records for Genetic Research- Results of the eMERGE consortium. Sci Transl Med 2011;3.Google Scholar
- 47.Biob ank UK. Published papers. www.http://www.ukbiobank.ac.uk/published-papers/. 2017.
- 53.Zanoni P. Rare Variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease. Science 2016;351.Google Scholar
- 55.Biobanks BE. Electronic medical records- enabling CostEffective research. Sci Transl Med. 2014;234Google Scholar
- 56.• Denny JC, Ritchie MD, Basford MA, Pulley JM, Bastarache L, Brown-Gentry K, Wang D, Masys DR, Roden DM and Crawford DC. PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations. Bioinformatics. 2010;26:1205–10. This article describes an electronic health record-based method to perform Phenome Wide Association Study (PheWAS), and demonstrates the efficacy of PheWAS on a variety of established SNP-disease associations. Google Scholar
- 62.Burgess SaSGT. Mendelian Randomization: Methods for Using Genetic Variants in Causal Estimation: Boca Raton: Chapman & Hall/CRC; 2015.Google Scholar
- 63.Kalia SS, Adelman K, Bale SJ, Chung WK, Eng C, Evans JP, et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med. 2017;19:249–55.CrossRefPubMedGoogle Scholar
- 68.Wright SM. Where do elderly veterans obtain Care for Acute Myocardial Infarction- Department of veterans affairs or Medicare? Health Serv Res 1997;31.Google Scholar
- 71.Biobank UK. Genotyping and quality control of UK biobank, a large-scale, extensively phenotyped prospective resource. UK Biobank Press Release 2015.Google Scholar